Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, Blood Stream Infections, Gastrointestinal Infections, and Other Healthcare-associated Infections), By Product Type (Consumables and Analyzers/Instruments), By Test Type (Traditional Diagnostics and Molecular Diagnostics), By End-User Type (Hospitals, Clinics, ASCs, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI411520 | Publish Date: May 2023 | No. of Pages: 168

Global Healthcareassociated Infectious Disease Diagnostics Overview

The infectious disease also called a communicable disease or transmissible disease is illness resulting from an infection. Infectious disease diagnostics is a process to identify the presence of foreign antigen/organisms with the help of various diagnostic tools. Healthcare associated Infectious Disease Diagnostic market accounted for US$ 3481.3 million in 2020 and is estimated to be US$ 6666.5 million by 2030 and is anticipated to register a CAGR of 7.50%.

Global Healthcareassociated Infectious Disease Diagnostics Dynamics

High prevalence along with the growing incidence of infectious diseases are major factors driving the global healthcare-associated infectious disease diagnostics market growth. Additionally, increasing government initiatives for the development of proper healthcare infrastructure in developing countries, technological advancements in diagnostic equipment, and high awareness about disease diagnostics in developed economies are other major factors estimated to propel the growth of the target market throughout the forecast period. However, lack of awareness about infectious disease diagnosis in emerging economies and increasing healthcare costs in developed economies are major factors hampering the growth of the global market. Further, lack of proper reimbursement policies in developed economies and in some emerging economies is another major factor anticipated to limit the growth of the global market over the forecast period. Nevertheless, increasing adoption of technologically advanced visual diagnostic equipment in healthcare institutions in developing economies is the major and rising trend for global market growth. This is another factor projected to boost the growth of the global market in the coming years.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Healthcareassociated Infectious Disease Diagnostics Segmentation

The global healthcare-associated infectious disease diagnostics market is segmented based on infection type, product type, test type, end-user type, and region.

On the basis of infection type, the global healthcare-associated infectious disease diagnostics market is segmented into urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, gastrointestinal infections, and other healthcare-associated infections. Based on product type, the global market is segmented into consumables and analyzers/instruments. On the basis of test type, the target market is bifurcated into Traditional diagnostics and molecular diagnostics. Based on end-user type, the global market is classified into hospitals, clinics, ASCs, and others.

 

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On the region, the global healthcare-associated infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America market dominates the global healthcare-associated infectious disease diagnostics market in terms of revenue currently, due to the high prevalence rate of infectious diseases coupled with the presence of a proper healthcare system in the region. The market in Europe estimates for second-largest revenue share in the global market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. Asia Pacific market is expected to witness the fastest growth in terms of revenue, due to the growing incidence of infectious diseases and rise in government initiatives for the improvement of healthcare facilities in developing economies in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Global Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type:

  • Urinary Tract Infections
  • Surgical Site Infections
  • Hospital-acquired Pneumonia
  • Blood Stream Infections
  • Gastrointestinal Infections
  • Other Healthcare-associated Infections

Global Healthcare-associated Infectious Disease Diagnostics Market, By Product Type:

  • Consumables
  • Analyzers/Instruments

Global Healthcare-associated Infectious Disease Diagnostics Market, By Test Type:

  • Traditional Diagnostics
  • Molecular Diagnostics

Global Healthcare-associated Infectious Disease Diagnostics Market, By End-user:

  • Hospitals
  • Clinics
  • ASCs
  • Others

Global Healthcare-associated Infectious Disease Diagnostics Market, By Region:

  • North America
  • North America Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
  • North America Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
  • North America Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
  • North America Healthcare-associated Infectious Disease Diagnostics Market, By End-user
  • North America Healthcare-associated Infectious Disease Diagnostics Market, By Country
    • U.S.
    • Canada
  • Europe
  • Europe Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
  • Europe Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
  • Europe Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
  • Europe Healthcare-associated Infectious Disease Diagnostics Market, By End-user
  • Europe Healthcare-associated Infectious Disease Diagnostics Market, By Country
    • Germany
    • UK
    • FranceRussia
    • Italy
    • Rest of Europe
  • Asia Pacific
  • Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
  • Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
  • Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
  • Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By End-user
  • Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market, By Country
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
      • Latin America
      • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
      • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
      • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
      • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By End-user
  • Latin America Healthcare-associated Infectious Disease Diagnostics Market, By Country
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type
    • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Product Type
    • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Test Type
    • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By End-user
    • Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Global Healthcareassociated Infectious Disease Diagnostics Key Players

The key players operating the global healthcare-associated infectious disease diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Diagnostics, bioMérieux SA, Becton-Dickinson & Company, Siemens Healthineers, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Sysmex Corporation, Beckman Coulter, and Danaher Corporation. Prominent players operating in the target market are focusing on the strategic partnerships as well as the launching of the products in order to gain a competitive edge in the target market. For instance, in 2018, F. Hoffmann-La Roche was involved in 23 successful diagnostic partnerships, which increases its product availability to targeted consumers.

Global Healthcareassociated Infectious Disease Diagnostics Company Profile

  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott Diagnostics
  • Biomérieux SA
  • Becton-Dickinson & Company
  • Siemens Healthineers
  • Thermo Fischer Scientific, Inc.
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • Danaher Corporation

 “*” marked represents similar segmentation in other categories in the respective section

Global Healthcareassociated Infectious Disease Diagnostics Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Healthcare-associated Infectious Disease Diagnostics Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Infection Type
      • Market Snippet, By Product Type
      • Market Snippet, By Test Type
      • Market Snippet, By End-user Vertical
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Healthcare-associated Infectious Disease Diagnostics Market, By Infection Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Urinary Tract Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Surgical Site Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hospital-acquired Pneumonia
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Blood Stream Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Gastrointestinal Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Healthcare-associated Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Healthcare-associated Infectious Disease Diagnostics Market, By Product Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Consumables
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Analyzers/Instruments
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Healthcare-associated Infectious Disease Diagnostics Market, By Test Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Traditional Diagnostics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Molecular Diagnostics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Healthcare-associated Infectious Disease Diagnostics Market, By End-user Vertical, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • ASCs
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Healthcare-associated Infectious Disease Diagnostics Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Test Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By End-user Vertical, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Test Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By End-user Vertical, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Test Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By End-user Vertical, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Test Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By End-user Vertical, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Test Type, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By End-user Vertical, 2020 – 2030
      • Market Healthcare-associated Infectious Disease Diagnostics and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Abbott Diagnostics
      • Biomérieux SA
      • Becton-Dickinson & Company
      • Siemens Healthineers
      • Thermo Fischer Scientific, Inc.
      • Bio-Rad Laboratories
      • Sysmex Corporation
      • Beckman Coulter
      • Danaher Corporation
  12. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Healthcare-associated Infectious Disease Diagnostics Market report segments based on the basis of infection type, product type, test type, end-user type, and region.

High prevalence along with the growing incidence of infectious diseases are major factors driving the global healthcare-associated infectious disease diagnostics market growth.

North America market dominates the global healthcare-associated infectious disease diagnostics market.

The leading players operating in the Healthcare-associated Infectious Disease F. Hoffmann-La Roche Ltd., Abbott Diagnostics, Biomérieux SA, Becton-Dickinson & Company, Siemens Healthineers, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Sysmex Corporation, Beckman Coulter, and Danaher Corporation.